ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Lipidomics Study of Sepsis-Induced Liver and Lung Injury under Anti-HMGB1 Intervention

Huang, Jiaxin; Wang, Zichen; Zhang, Xuyu; Gou, Yuanyuan; Li, Jing; Guan, Su*; Zhang, Hufei*中山大学; 1
Journal of Proteome Research2023-3-31DOI: 10.1021/acs.jproteome.2c00851
3被引3阅读
引用收藏
分享

摘要

Sepsis usually leads to lethal multiorgan dysfunction including acute liver failure (ALF) and acute lung injury (ALI). This research sought to reveal the lipid alteration of anti-high mobility group box 1 (HMGB1) treatment in sepsis-induced ALF and ALI by lipidomics. The cecal ligation and puncture-induced mouse model was established and the anti-HMGB1 neutralizing antibody was administrated. The histopathological characteristics and inflammatory factors were determined to assess the efficacy of the antibody. Utraperformance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry was used to determine lipid metabolism profiles in the liver and lung. The underlying biomarkers were identified through multivariate statistical analysis and correlation analysis with traditional physiological indicators. The pathological and biochemical results demonstrated that anti-HMGB1 neutralizing antibodies mitigated ALF and ALI in mice. Three differential metabolites in the liver and six various metabolites in the lung were significantly reversed by anti-HMGB1 treatment, mainly involved in arachidonic acid metabolism, glycerophospholipid metabolism, and sphingolipid metabolism. Additionally, we investigated several traditional signaling pathways associated with HMGB1. However, the correlation between these traditional pathways and anti-HMGB1 intervention was not significant in the current study. In conclusion, our finding provided some scientific basis for targeting HMGB1 in sepsis-induced liver and lung injury. Mass spectrometry data with identifier no. MTBLS6466 have been uploaded to MetaboLights (http://www.ebi.ac.uk/metabolights/login).

学科与关键词

关键词
sepsisHMGB1ALFALIUPLC-Q-TOFMSlipidomics
相关
加载中…
  • Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury
    Deng, Chao; Zhao, Lin; Yang, Zhi; Shang, Jia-jia; Wang, Chang-yu; Shen, Ming-zhi; Jiang, Shuai; Li, Tian; Di, Wen-cheng; Chen, Ying; Li, He; Cheng, Ye-dong*; Yang, Yang*Acta Pharmacologica Sinica, 2022, 43(3): 520-528.被引 35
  • Identification of Key Metabolites for Acute Lung Injury in Patients with Sepsis
    Wang, Pei-Quan; Li, Jing; Zhang, Li-Li; Lv, Hong-Chun; Zhang, Su-Hua*IRANIAN JOURNAL OF PUBLIC HEALTH, 2019, 48(1): 77-84.被引 3
  • Sacubitril/valsartan alleviates sepsis-induced acute lung injury via inhibiting GSDMD-dependent macrophage pyroptosis in mice
    Wang, Jun; Li, Jierui; Lou, Anni; Lin, Ying; Xu, Qihan; Cui, Wanfu; Huang, Weichang; Wang, Guozhen; Li, Yang; Sun, Jing; Gong, Jiacheng; Guo, Qiuping; Qiu, Hongshen; Meng, Ying*; Li, Xu*FEBS Journal, 2023, 290(8): 2180-2198.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Proteome Research
发表日期
2023-03-31
卷期
第 22 卷, 第 6 期
页码
1881-1895
DOI
10.1021/acs.jproteome.2c00851
语言
ENGLISH
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province, China [2021A1515010990]

作者

  • H

    Huang, Jiaxin (第一作者)

  • W

    Wang, Zichen

查看全部 7 位作者收起作者
  • Z

    Zhang, Xuyu

    1 · sun yat sen univ

  • G

    Gou, Yuanyuan

  • L

    Li, Jing

  • G

    Guan, Su (通讯)

  • Z

    Zhang, Hufei (通讯)

    1 · sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417